BioGaia AB (publ)

Stockholm Stock Exchange BIOG-B.ST

BioGaia AB (publ) Price to Earnings Ratio (P/E) on February 03, 2025: 30.06

BioGaia AB (publ) Price to Earnings Ratio (P/E) is 30.06 on February 03, 2025, a 2.43% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

BioGaia AB (publ) 52-week high Price to Earnings Ratio (P/E) is 35.51 on March 05, 2024, which is 18.14% above the current Price to Earnings Ratio (P/E).
BioGaia AB (publ) 52-week low Price to Earnings Ratio (P/E) is 25.55 on October 23, 2024, which is -14.99% below the current Price to Earnings Ratio (P/E).
BioGaia AB (publ) average Price to Earnings Ratio (P/E) for the last 52 weeks is 31.08.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Stockholm Stock Exchange: BIOG-B.ST

BioGaia AB (publ)

CEO	Ms. Theresa P. Agnew
IPO Date	Jan. 3, 2000
Location	Sweden
Headquarters	Kungsbroplan 3
Employees	222
Sector	Consumers Staples
Industries Dairy & Milk Baby & Childcare Biotechnology Frozen Foods Non-Alcoholic Beverages Personal Care Pharmaceuticals Plastics

Description

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylorithe gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

Key trends

Past 5 years